Kitzerow’s Documented Timeline

On Kimberly's nonverbal autistic daughter's fourth birthday, her daughter couldn't blow out birthday candles. Kimberly realized her daughter's inability to speak was not a cognitive limitation but a physiological one. This shifted her understanding of autism's origins and led to the first conceptual outline of a biochemical, rather than behavioral, hypothesis.

Kimberly authored the foundational instructional neuroplasticity strategies that would become the NeuroToggle® framework. These principles formed the core of a structured learning model that ultimately helped transition her daughter from silence to chatterbox. (She would later learn that this worked because autism is an allostatic existence that shifts which proteins are active during critical developmental windows, prioritizing allostatic proteins over neural circuitry development. Neuroplasticity overrode that process, reprioritizing neural development.)

Kimberly identified a pattern in stress-induced hyperglycemia as a redox protein shift, identifying it as the first sign of a toggle-like biochemical response to strain in autistics (would later represent the Metabolism BioToggle). This is where she started putting together the bioinformatics research on a map.

Kimberly began formally documenting her Discovery of Autism and the Comorbidities Along the BH4 Pathway on social media, built visually using Adobe Illustrator as she constructed her proprietary biochemical network.

Kimberly announced the exclusivity principle: autism and the comorbidities can't occur simultaneously without a joint root cause in the same subset of people. It is mechanistically improbable. She stated that her methods included factoring in three principles: the autism comorbidities must happen simultaneously or as a secondary condition to a primary, autism is something you're born with, any brain research/testing observed after birth are likely impacted by neuroplasticity, positive or negative making current interpretations of relevant data invalid, and research indicates a progressive decline in symptoms.

Kimberly linked glucose dysregulation and BH4. Metformin, a diabetic treatment, increases GCH1 and BH4 levels. This, in her map, linked the resolution of stress hyperglycemia linking BH4 to the stress response system as a regulatory factor. This is when she realized it is the center linchpin of the stress response system.

Kimberly formally announced this timeline as her living documentary to protect intellectual property.

Kimberly formally established Kimberly's Educational Resources LLC to secure intellectual property rights, manage trademarks, and publicly disseminate the frameworks she had created. She also published "Discovering Autism and the Comorbidities Along the BH4 Pathway"—a memoir created to publicly timestamp the origin of her hypothesis.

Kimberly published the first formal version of her hypothesis on ResearchGate. She coined the field "Neurodivergent Biochemistry"—a systems-level framework that explains neurodivergence as a biochemically adaptive, allostatic state rather than a localized neurodevelopmental brain disorder. It is based on the principle that: Genetic mutations and allostatic shifts alter which proteins are active (epigenetics) during critical developmental windows, impair system function, and lead to biochemical wear and tear over time from allostatic overload. This ultimately results in divergence in development, function, and development of chronic conditions. Phenotypes vary depending on when in development the shifts occur and how long they persist.

Kimberly's daughter was formally disenrolled from CLTS disability services after she was deemed no longer functionally eligible.

Kimberly was accepted to UW Madison's Bioinformatics program. She started a GoFundMe to pay for tuition as a single mom and hit her goal within 24 hours because advancing neurodivergent biochemistry had so much support.

Kimberly realized there was a broader pattern of redox protein shifts in neurodivergent biomarkers and extended her hypothesis. She published "Genomic and Proteomic Regulation in Cellular Homeostasis: From Molecular Mechanisms to Clinical Implications" on ResearchGate.

Kimberly was formally accepted and enrolled at UW Madison for Bioinformatics.

Kimberly released the regulatory system toggles framework that she would later call the BioToggles™.

Kimberly published NeuroToggle™ on Amazon—an instructional framework on how to strengthen, time, expand, and initiate neural connections through intentional instruction strategies and teaching pedagogy.

Researchers at a university in Brazil submitted their plagiarism of Kimberly's hypothesis to a journal: "Tetrahydrobiopterin and Autism Spectrum Disorder: A Systematic Review of a Promising Therapeutic Pathway."

Kimberly completed trademark registration for NeuroToggle™.

The plagiarized paper passed peer review and was published in MDPI: "Tetrahydrobiopterin and Autism Spectrum Disorder: A Systematic Review of a Promising Therapeutic Pathway."

Kimberly discovered the plagiarized paper and called her D.C. representative to ask what next steps would be for helping more kids if this is accurate.

Kimberly got a call back from her D.C. representative asking what she did for her nonverbal autistic daughter and how. She told him she synthesized existing research and figured out the pathology of autism to help take her from silence to speech, and that her hypothesis was recently plagiarized and peer-reviewed in Brazil.

RFK announced his plan to synthesize autism research to figure out the pathology of autism for nonverbal kids. When asked about his reasoning, he could not support it. He said he would request others to come and bid on how to do the research. When they couldn't find a good bid on how to actually synthesize the existing research across disciplines, he backtracked the timeline and said they're going to replicate some of the studies that have already been done. When they couldn't find a valid route forward with a human, they deferred to AI to attempt to follow through on their "promise."

Kimberly turned the allostatic toggles framework into the BioToggles and trademarked BioToggle.

Kimberly published a paper titled "BioToggle™ Categorical Delineation: A Functional Framework for Timing-Sensitive Intervention in Neurodivergent Biochemistry," which includes the Toggle-Based Neurotype Classification System™ - Maps neurotypes to situational, chronic, or genetic BioToggle™ states, with varying phenotypes of neurodivergence depending on when in development the shifts occur and how long they persist.

Kimberly published NeuroToggle 2.

Kimberly's dad texted her and told her about Princeton's paper that overlapped with her methods and conclusions that each autism phenotype with comorbidities link to clusters based on biochemical pathway dysfunction. This is the third time her work was taken uncredited, so she did a breakdown with screenshots on the texts with her parents and how she found out each time.

Kimberly created the BioDials to explain the time regulated flow of protein synthesis that maintains physiological function and development.